Rationale for treating primary Sjögren’s syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab)

Title
Rationale for treating primary Sjögren’s syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab)
Authors
Keywords
Sjögren’s syndrome, CD6, Itolizumab, B cells
Journal
IMMUNOLOGIC RESEARCH
Volume 56, Issue 2-3, Pages 341-347
Publisher
Springer Nature
Online
2013-04-10
DOI
10.1007/s12026-013-8423-x

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now